Birth Weight Linked to Risk of Certain Pediatric Cancers
Birth weight may be associated with the risk of certain pediatric cancers, a new study suggests.
Birth weight may be associated with the risk of certain pediatric cancers, a new study suggests.
Patients who have more mitochondrial DNA fraction breaks have a higher risk of developing non-Hodgkin lymphoma, according to new research.
Survivors of common lymphoid neoplasms have an increased risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia, data suggest.
An investigation into cancer cases linked to a nuclear missile base revealed unsafe levels of polychlorinated biphenyls.
Studies presented at the ASCO Annual Meeting 2023 highlighted new developments in lymphoma that could lead to changes in practice.
Rates of CNS relapse are similar in DLBCL patients who receive high-dose IV methotrexate and those who receive IT methotrexate, phase 3 data suggest.
Epkinly (epcoritamab-bysp) is approved to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B-cell lymphoma after 2 or more lines of systemic therapy.
The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say.
Exposure to 4 or more CT scans before the age of 18 is associated with an increased risk of intracranial tumors, leukemia, and lymphoma, a study suggests.
Polivy plus R-CHP is approved for the first-line treatment of patients with DLBCL NOS or HGBL who have an IPI score of 2 or greater.